I. Name of Project: Levofloxacin Hydrochlo-Ride Bacteriophage Type Medicine Production Line.
II. Outline of Project: Liaoning Beiqi Pharmaceutical Co., Ltd. changed its ownership in October 2000. The registered capital: 20,100,000 Yuan, the factory’s floor area is 12,360 square meters and the building area is 7,800 square meters. The new factory area installs two production lines of medical powder, two production lines of the troche and capsule, one production line of pulvis and the raw material compound workshop. The annual output of powder of 5000 pieces, the troche of 0.4 billion pieces, capsule: 0.2 billion pieces, the annual production value: 18,000,000 Yuan. The enterprise passed the certification of National Medicine Production Quality Control Norm in 2002 and in 2004. The factory’s product “Paraniazide’s Raw Material and Troche” obtained the second prize of the Outstanding New Product of Liaoning Province in 1998, The product “hydrochloric acid Levofloxacin Hydrochlo-Ride Raw Material and Troche” obtained the second prize of the Science and technology progress of Liaoning Province in 2002.
III. Background of Project: At present, the demand of the bacteriophage in china in the market is very great. It consists mainly of bacteriophage such as β- amide, carbostyri and macrolide. The share of market of the bacteriophage such as carbostyril type medicine is approximate 30%. Its main medicine is norfloxacin, Ciprofloxacin, ofloxacin and Levofloxacin Hydrochlo-Ride, etc. The demand of ofloxacin is the greatest. As the fourth generation of bacteriophage medicinesuch as carbostyril, Levofloxacin Hydrochlo-Ride is ofloxacin is the updating and upgrading product, its clinic dosage only is onehalf of ofloxacin, but its curative effect is obviously better than ofloxacin. Since Levofloxacin Hydrochlo-Ride is sold in the market, the medicine is approved and praised by the medical personnel and patients. In addition, the medicine can destroy SARS virus. Our country has listed the medicine in the rank of the bacteriophage to treat “SARS”.
IV. Building Size and Content: The total investment of the project is 80,000,000 Yuan. Build production line with the annual output of the raw material of 50 tons and troche of 60,000,000 pieces.
V. Geographical Position, Traffic and Transportation and Communication: The project is planned to be built in Dandong Industrial Zone. The railways of Dandong City can reach directly the main cities in China. The city has the convenient traffic, perfect communication and enough water and electricity supply.
VI. Analysis on Benefit: After completing the project, the annual sales income will be 120,000,000 Yuan, the profits and taxes will be 30,000,000 Yuan and the profit will be 17000,000 Yuan. The repayment period of investment is 2 year.
VII. Form of Investment: Joint venture, cooperation.
Unit: Dandong Industrial Zone Administration Committee of Liaoning Province
Address: Room 2104-2107, Building A, Taiyang Building, No. 128, Binjiang Middle Road, Dandong City
Contact Person: Liu Zecheng
Telephone: 0415-6199711, 6166911